16Jun
Diligence Clauses and the Management of Uncertainty in Life Sciences Agreements
In times of uncertainty and disruption, setting expectations for performance with business partners and contractual counterparties can be more complicated than ever. Companies that develop drugs, biologics and medical devices have considerable...
By:
Skadden, Arps, Slate, Meagher & Flom LLP
Related
Seyfarth Synopsis: Establishments with 250 or more employees that are currently required to keep OS...
Read More >
In today’s edition of Daily Compliance News: 1. Citgo 6 rearrested in Venezuela. (HoustonChronicle...
Read More >
On September 23, 2019, the Treasury Department and IRS published final regulations for hardship dist...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
Last week, the U.S. Department of Labor issued its Final Rule regarding the salary thresholds that a...
Read More >
Foreign investment control has become a key factor in M&A deals and 2020 has been an eventful year. ...
Read More >